Berk M - Search Results

1

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms.

Neill E, Rossell SL, Yolland C, Meyer D, Galletly C, Harris A, Siskind D, Berk M, Bozaoglu K, Dark F, Dean OM, Francis PS, Liu D, Phillipou A, Sarris J, Castle DJ. Neill E, et al. Among authors: berk m. Schizophr Bull. 2022 Nov 18;48(6):1263-1272. doi: 10.1093/schbul/sbac065. Schizophr Bull. 2022. PMID: 35857752 Free PMC article. Clinical Trial.

2

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use.

Jespersen S, Berk M, Van Wyk C, Dean O, Dodd S, Szabo CP, Maud C. Jespersen S, et al. Among authors: berk m. Int Clin Psychopharmacol. 2004 May;19(3):161-4. doi: 10.1097/00004850-200405000-00007. Int Clin Psychopharmacol. 2004. PMID: 15107659 Clinical Trial.

3

A collaborative approach to the treatment alliance in bipolar disorder.

Berk M, Berk L, Castle D. Berk M, et al. Among authors: berk l. Bipolar Disord. 2004 Dec;6(6):504-18. doi: 10.1111/j.1399-5618.2004.00154.x. Bipolar Disord. 2004. PMID: 15541066 Review.

4

A clinical monitoring system for clozapine.

Castle D, Lambert T, Melbourne S, Cox A, Boardman G, Fairest K, Davy M, Goh J, Kuluris B, Berk M. Castle D, et al. Among authors: berk m. Australas Psychiatry. 2006 Jun;14(2):156-68. doi: 10.1080/j.1440-1665.2006.02267.x. Australas Psychiatry. 2006. PMID: 16734644

5

Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.

Berk M, Fitzsimons J, Lambert T, Pantelis C, Kulkarni J, Castle D, Ryan EW, Jespersen S, McGorry P, Berger G, Kuluris B, Callaly T, Dodd S. Berk M, et al. CNS Drugs. 2007;21(2):117-27. doi: 10.2165/00023210-200721020-00003. CNS Drugs. 2007. PMID: 17284094 Review.

6

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

Ng F, Berk M, Dean O, Bush AI. Ng F, et al. Among authors: berk m. Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Epub 2008 Jan 21. Int J Neuropsychopharmacol. 2008. PMID: 18205981 Free article. Review.

7

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI. Berk M, et al. Biol Psychiatry. 2008 Sep 1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23. Biol Psychiatry. 2008. PMID: 18436195 Clinical Trial.

8

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI. Berk M, et al. Biol Psychiatry. 2008 Sep 15;64(6):468-75. doi: 10.1016/j.biopsych.2008.04.022. Epub 2008 Jun 5. Biol Psychiatry. 2008. PMID: 18534556 Clinical Trial.

9

Glutathione: a novel treatment target in psychiatry.

Berk M, Ng F, Dean O, Dodd S, Bush AI. Berk M, et al. Trends Pharmacol Sci. 2008 Jul;29(7):346-51. doi: 10.1016/j.tips.2008.05.001. Epub 2008 Jun 4. Trends Pharmacol Sci. 2008. PMID: 18538422 Review.

10

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. Dodd S, et al. Among authors: berk m. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. Expert Opin Biol Ther. 2008. PMID: 18990082 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,588 results

Search Page